Research
FORUM TRANSCRIPT

Small Molecule Manufacturing – CDMO M&A Update & Market Outlook – 23 November 2021

  • Private Equity
  • Healthcare
  • North America
PREMIUM

Specialist

Former VP at Lonza Group AG

Agenda

  • Recent trends and developments in small molecule manufacturing
  • Competitive landscape of top CDMOs (contract development manufacturing organisations) and emerging players, plus consolidation trends
  • Expected growth of small molecule outsourced manufacturing vs biologics
  • Margin profiles, potential headwinds, 2022 M&A expectations and growth opportunities

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo